🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Standard ADT (androgen deprivation therapy)

Found 150 matching trials

An Observational Study Conducted in China to Evaluate the Efficacy and Safety of Darolutamide in Combination With Androgen Deprivation Therapy (ADT) for Men With Non-metastatic Prostate Cancer That Progressed Following Prior Bicalutamide + ADT Treatment

N/A

In this observational study, participants receive darolutamide: a treatment...

Status

Recruiting

Location

Many locations

Start Date

2026-07-31

Trial ID

NCT07538843

Treatments Being Tested

Darolutamide ADT

Docetaxel or Abiraterone Acetate With ADT in Treating Patients With Metastatic Hormone Sensitive Prostate Cancer

PHASE2

This phase II trial studies how well docetaxel or abiraterone acetate work ...

Status

Terminated

Location

Huntsman Cancer Institute/University of Utah

Start Date

2019-02-08

Trial ID

NCT03827473

Treatments Being Tested

Abiraterone Acetate Antiandrogen Therapy Docetaxel Prednisone Quality-of-Life Assessment Questionnaire Administration

A Study to Learn How Men With Advanced Prostate Cancer Respond to Treatment With Darolutamide and Hormone Therapy, With or Without Chemotherapy, in Real-world Medical Practice

N/A

This is an international, prospective, open-label, multicenter, multi-cohor...

Status

Active Not Recruiting

Location

Many Locations

Start Date

2026-01-29

Trial ID

NCT07344779

Treatments Being Tested

Darolutamide (BAY 1841788)ADT Docetaxel

Oral Docetaxel (ModraDoc/r) in Combination With Hormonal Treatment and Radiation Therapy in High-risk Prostate Cancer

PHASE1

The optimal treatment for HRPC patients has not yet been established. Recen...

Status

Terminated

Location

Netherlands Cancer Institute

Start Date

2016-09

Trial ID

NCT03066154

Treatments Being Tested

oral docetaxel (ModraDoc/r)androgen deprivation therapy high-dose intensity-modulated radiation therapy

A Study of Participants With Advanced Prostate Cancer in Canada

N/A

The purpose of this study is to document the course of advanced prostate ca...

Status

Completed

Location

Tom Baker Cancer Center

Start Date

2018-04-12

Trial ID

NCT03501173

Treatments Being Tested

Standard of Care

ADT and SBRT vs SBRT Alone for Unfavorable Intermediate Risk Prostate Cancer

PHASE2

For this study, unfavorable intermediate risk prostate cancer patients will...

Status

Recruiting

Location

NYU Langone Health

Start Date

2024-04-16

Trial ID

NCT06397703

Treatments Being Tested

Leuprolide, Degarelix or Relugolix Stereotactic body radiation therapy/radiosurgery (SBRT)

A Trial Comparing Docetaxel 75 mg/m2 (3w) Versus Docetaxel 50 mg/m2 (2w) in Combination With Darolutamide + ADT in mHSPC Patients

PHASE3

The purpose of this clinical phase 3 randomized trial is to compare two dif...

Status

Active Not Recruiting

Location

Ordensklinikum Linz GmbH, Elisabethinen

Start Date

2023-05-16

Trial ID

NCT05676203

Treatments Being Tested

Standard ADT (androgen deprivation therapy)Standard Darolutamide Docetaxel

Darolutamide + Androgen Deprivation Therapy (ADT) in Chinese Men With High Risk, Nonmetastatic Prostate Cancer

PHASE2

Researchers are seeking better ways to treat men who have non-metastatic ca...

Status

Completed

Location

Many Locations

Start Date

2021-11-30

Trial ID

NCT05171387

Treatments Being Tested

Darolutamide 600 mg twice daily Androgen deprivation therapy (ADT)

Adaptive Stereotactic Body Radiation Therapy to the Prostate and Pelvic Nodes With Simultaneous Integrated Boost to the MR-detected Nodule for Patients With High-risk and Unfavorable Intermediate-risk Prostate Cancer

This trial is a prospective clinical trial designed to demonstrate the safe...

Status

Active Not Recruiting

Location

Washington University School of Medicine

Start Date

2023-01-18

Trial ID

NCT05628363

Treatments Being Tested

Ethos Varian treatment system Adaptive stereotactic body radiotherapy Androgen deprivation therapy

Collection and Measurement of Biomarkers in Prostate Cancer Radiotherapy Patients

N/A

The purpose of this research study is to learn about: 1) How standard radia...

Status

Recruiting

Location

University of Miami

Start Date

2016-06-24

Trial ID

NCT02997709

Previous Next